DexCom EBITDA 2006-2019 | DXCM
DexCom annual and quarterly EBITDA history from 2006 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- DexCom EBITDA for the quarter ending June 30, 2019 was $0.011B, a 500% increase year-over-year.
- DexCom EBITDA for the twelve months ending June 30, 2019 was $-0.128B, a 4313.79% increase year-over-year.
- DexCom 2018 annual EBITDA was $-0.157B, a 495.45% increase from 2017.
- DexCom 2017 annual EBITDA was $-0.026B, a 46.01% decline from 2016.
- DexCom 2016 annual EBITDA was $-0.049B, a 5.62% increase from 2015.
| DexCom Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $-157 |
| 2017 | $-26 |
| 2016 | $-49 |
| 2015 | $-46 |
| 2014 | $-13 |
| 2013 | $-21 |
| 2012 | $-48 |
| 2011 | $-40 |
| 2010 | $-42 |
| 2009 | $-42 |
| 2008 | $-50 |
| 2007 | $-44 |
| 2006 | $-47 |
| 2005 | $-31 |
| DexCom Quarterly EBITDA (Millions of US $) |
|
|---|---|
| Q2 2019 | $11 |
| Q1 2019 | $-5 |
| Q4 2018 | $-156 |
| Q3 2018 | $22 |
| Q2 2018 | $2 |
| Q1 2018 | $-25 |
| Q4 2017 | $16 |
| Q3 2017 | $4 |
| Q2 2017 | $-10 |
| Q1 2017 | $-37 |
| Q4 2016 | $-3 |
| Q3 2016 | $-14 |
| Q2 2016 | $-16 |
| Q1 2016 | $-16 |
| Q4 2015 | $4 |
| Q3 2015 | $-40 |
| Q2 2015 | $-1 |
| Q1 2015 | $-10 |
| Q4 2014 | $4 |
| Q3 2014 | $-3 |
| Q2 2014 | $-4 |
| Q1 2014 | $-10 |
| Q4 2013 | $-0 |
| Q3 2013 | $-4 |
| Q2 2013 | $-8 |
| Q1 2013 | $-9 |
| Q4 2012 | $-6 |
| Q3 2012 | $-15 |
| Q2 2012 | $-13 |
| Q1 2012 | $-14 |
| Q4 2011 | $-11 |
| Q3 2011 | $-12 |
| Q2 2011 | $-6 |
| Q1 2011 | $-11 |
| Q4 2010 | $-9 |
| Q3 2010 | $-12 |
| Q2 2010 | $-10 |
| Q1 2010 | $-10 |
| Q4 2009 | $-9 |
| Q3 2009 | $-11 |
| Q2 2009 | $-12 |
| Q1 2009 | $-10 |
| Q4 2008 | $-12 |
| Q3 2008 | $-13 |
| Q2 2008 | $-13 |
| Q1 2008 | $-12 |
| Q4 2007 | $-12 |
| Q3 2007 | $-11 |
| Q2 2007 | $-11 |
| Q1 2007 | $-11 |
| Q4 2006 | $-11 |
| Q3 2006 | $-14 |
| Q2 2006 | $-11 |
| Q1 2006 | $-11 |
| Q4 2005 | $-12 |
| Q3 2005 | $-7 |
| Q2 2005 | $-7 |
| Q1 2005 | $-6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $15.345B | $1.032B |
| Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $110.607B | 23.57 |
| Intuitive Surgical (ISRG) | United States | $57.377B | 50.18 |
| Edwards Lifesciences (EW) | United States | $46.171B | 44.94 |
| IDEXX Laboratories (IDXX) | United States | $24.227B | 60.78 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $20.503B | 13.58 |
| Teleflex (TFX) | United States | $17.007B | 36.10 |
| Olympus (OCPNY) | Japan | $16.422B | 122.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.907B | 0.00 |
| Hologic (HOLX) | United States | $13.352B | 21.08 |
| Sysmex ADR (SSMXY) | Japan | $12.966B | 34.96 |
| STERIS (STE) | Ireland | $12.795B | 29.51 |
| Varian Medical Systems (VAR) | United States | $9.840B | 23.54 |
| ABIOMED (ABMD) | United States | $8.741B | 50.03 |
| Masimo (MASI) | United States | $8.124B | 49.29 |
| SARTORIUS AG (SARTF) | Germany | $6.158B | 54.71 |
| Integra LifeSciences Holdings (IART) | United States | $5.239B | 23.38 |
| Penumbra (PEN) | United States | $5.024B | 180.50 |
| Globus Medical (GMED) | United States | $4.990B | 31.67 |
| Elekta AB (EKTAY) | Sweden | $4.803B | 38.32 |
| LivaNova (LIVN) | United Kingdom | $3.912B | 29.83 |
| Cantel Medical (CMD) | United States | $3.689B | 37.43 |
| Tandem Diabetes Care (TNDM) | United States | $3.596B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.735B | 239.89 |
| Nevro (NVRO) | United States | $2.563B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.551B | 25.67 |
| Integer Holdings (ITGR) | United States | $2.518B | 17.81 |
| Glaukos (GKOS) | United States | $2.293B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.701B | 31.56 |
| Silk Road Medical (SILK) | United States | $1.253B | 0.00 |
| Veracyte (VCYT) | United States | $1.251B | 0.00 |
| OPKO Health (OPK) | United States | $1.231B | 0.00 |
| Natus Medical (NTUS) | United States | $1.034B | 24.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.996B | 31.27 |
| Accelerate Diagnostics (AXDX) | United States | $0.981B | 0.00 |
| CryoLife (CRY) | United States | $0.981B | 93.43 |
| Tactile Systems Technology (TCMD) | United States | $0.954B | 117.91 |
| Inogen (INGN) | United States | $0.917B | 22.48 |
| Luminex (LMNX) | United States | $0.916B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.891B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.878B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.856B | 39.54 |
| AngioDynamics (ANGO) | United States | $0.704B | 23.02 |
| Quotient (QTNT) | Switzerland | $0.674B | 0.00 |
| AxoGen (AXGN) | United States | $0.640B | 0.00 |
| Intersect ENT (XENT) | United States | $0.500B | 0.00 |
| Si-Bone (SIBN) | United States | $0.485B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Fluidigm (FLDM) | United States | $0.419B | 0.00 |
| ViewRay (VRAY) | United States | $0.414B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.376B | 14.43 |
| Alphatec Holdings (ATEC) | United States | $0.367B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.366B | 0.00 |
| Sientra (SIEN) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.299B | 50.55 |
| Accuray (ARAY) | United States | $0.247B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.238B | 35.78 |
| IRadimed (IRMD) | United States | $0.235B | 38.92 |
| CRH Medical (CRHM) | Canada | $0.231B | 80.25 |
| SeaSpine Holdings (SPNE) | United States | $0.218B | 0.00 |
| TransEnterix (TRXC) | United States | $0.213B | 0.00 |
| Stereotaxis (STXS) | United States | $0.188B | 0.00 |
| Neuronetics (STIM) | United States | $0.183B | 0.00 |
| ConforMIS (CFMS) | United States | $0.139B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.073B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.065B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.062B | 0.00 |
| Vermillion (VRML) | United States | $0.054B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.048B | 0.00 |
| Electromed (ELMD) | United States | $0.044B | 22.61 |
| T2 Biosystems (TTOO) | United States | $0.040B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.038B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.028B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.027B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.027B | 0.00 |
| Nuvectra (NVTR) | United States | $0.026B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.026B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.023B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.018B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 21.58 |
| Lianluo Smart (LLIT) | China | $0.014B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.013B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.012B | 0.00 |
| Dynatronics (DYNT) | United States | $0.011B | 0.00 |
| Avinger (AVGR) | United States | $0.011B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
| Micron Solutions (MICR) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.006B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.005B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.005B | 0.00 |
| InspireMD (NSPR) | Israel | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
